When fragments link: a bibliometric perspective on the development of fragment-based drug discovery

Angelo K.S. Romasanta, Peter van der Sijde, Iina Hellsten, Roderick E. Hubbard, Gyorgy M. Keseru, Jacqueline van Muijlwijk-Koezen, Iwan J.P. de Esch*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.
Original languageEnglish
Pages (from-to)1596-1609
Number of pages14
JournalDrug Discovery Today
Volume23
Issue number9
Early online date5 May 2018
DOIs
Publication statusPublished - Sept 2018

Funding

This work was supported by the European Union’s Horizon2020 MSCA Program under grant agreement 675899 (FRAGNET).

FundersFunder number
European Union's Horizon2020 MSCA
European Union’s Horizon2020 MSCA
Horizon 2020 Framework Programme675899

    Fingerprint

    Dive into the research topics of 'When fragments link: a bibliometric perspective on the development of fragment-based drug discovery'. Together they form a unique fingerprint.

    Cite this